FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Bae I Paul

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/16/2015 

3. Issuer Name and Ticker or Trading Symbol

ST JUDE MEDICAL INC [STJ]

(Last)        (First)        (Middle)

ONE ST. JUDE MEDICAL DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
VP Global HR and CCO /

(Street)

ST. PAUL, MN 55117       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   9229   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy)   12/10/2008   (1) 12/10/2015   Common Stock   34000   $40.55   D    
Stock Options (Right to Buy)   12/15/2009   (1) 12/15/2016   Common Stock   24000   $30.58   D    
Stock Options (Right to Buy)   12/14/2010   (1) 12/14/2017   Common Stock   30000   $38.59   D    
Stock Options (Right to Buy)   12/14/2011   (1) 12/14/2018   Common Stock   19996   $41.65   D    
Stock Options (Right to Buy)   12/17/2012   (2) 12/12/2019   Common Stock   22000   $34.96   D    
Restricted Stock Units   12/17/2012   (3)   (4) Common Stock   714     (4) D    
Stock Options (Right to Buy)   12/17/2013   (2) 12/10/2020   Common Stock   19816   $35.27   D    
Restricted Stock Units   12/17/2013   (3)   (4) Common Stock   1238     (4) D    
Stock Options (Right to Buy)   12/17/2014   (2) 12/10/2021   Common Stock   9332   $59.41   D    
Restricted Stock Units   12/17/2014   (3)   (4) Common Stock   840     (4) D    
Stock Options (Right to Buy)   12/17/2015   (2) 12/8/2022   Common Stock   8068   $69.08   D    
Restricted Stock Units   12/17/2015   (3)   (4) Common Stock   916     (4) D    

Explanation of Responses:
( 1)  Fully vested at the time of filing.
( 2)  The option shares will vest 25% on December 17th annually beginning the date shown.
( 3)  The restricted stock units will vest 25% on December 17th annually beginning the date shown.
( 4)  Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Bae I Paul
ONE ST. JUDE MEDICAL DRIVE
ST. PAUL, MN 55117


VP Global HR and CCO

Signatures
/s/ Kashif Rashid, Attorney in Fact 2/18/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
SJM (NYSE:STJ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more SJM Charts.
SJM (NYSE:STJ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more SJM Charts.